Results 101 to 110 of about 12,566 (192)

In vitro examination of the effect of orlistat on the ability of the faecal microbiota to utilize dietary lipids

, 2009
Orlistat is an anti-obesity treatment with which several gastrointestinal (GI) side-effects are commonly associated in the initial stages of therapy. There is no physiological explanation as to why two-thirds of those who take the drug experience one or ...
Hoyles, L.
core  

Pharmacodynamic testing and new validated HPLC method to assess the interchangeability between multi-source orlistat capsules

Drug Design, Development and Therapy, 2017
Abdel Naser Zaid,1 Nihal Zohud,1 Bushra E’layan,1 Tasneem Aburadi,1 Nidal Jaradat,1 Iyad Ali,2 Fatima Hussein,1 Mashhour Ghanem,3 Aiman Qaddomi,3 Yara Abu Zaaror4 1Department of Pharmacy, 2Department of Biomedical Sciences, Faculty of Medicine and
Zaid AN, Zohud N, E'layan B, Aburadi T, Jaradat N, Ali I, Hussein F, Ghanem M, Qaddomi A, Abu Zaaror Y   +9 more
doaj  

Orlistat Suppresses Small Intestinal Neuroendocrine Tumor Growth Through ATF3-Associated Stress and Ferroptosis-Related Responses-In Vitro and Cell Line Xenograft Evidence. [PDF]

Cancers (Basel)
Zeng X, Chen S, Long Q, Han X, Li W, Ge J, Ding Y, Ding Y, Ye M, Tang Q.   +9 more
europepmc   +1 more source

Orlistat: a comprehensive review of a lipase inhibitor from obesity management to emerging oncological applications. [PDF]

Front Pharmacol
Li L, Hao Y.
europepmc   +1 more source

Supramolecular self-assembled nanomedicine targeting fatty acid metabolism to potentiate ferroptosis-enhanced photoimmunotherapy in triple-negative breast cancer. [PDF]

Mater Today Bio
Li F, Wu J, Hao X, Xu W, Wang J, Zhang J, Wei X, Feng N, Liu F, Liao D.   +9 more
europepmc   +1 more source

Protective effects of Crocin on hepatic steatosis, oxidative stress, and lipid profile in an animal model of non-alcoholic fatty liver disease. [PDF]

PLoS One
Rezayee H, Fahmidehkar MA, Beheshti F, Ghoryani M, Yousefpoor Y, Hossaini D, Ilbeigi D.   +6 more
europepmc   +1 more source

Orlistat-Associated Gastrointestinal, Hepatobiliary, Pancreatic, and Anorectal Safety Signals: A FAERS Disproportionality and Regulatory Label Concordance Study. [PDF]

Pharmaceuticals (Basel)
Öğütmen Koç D, Sarbay İ, Mercan Başpınar M, Mangal L, Arda BE, Sipahi H.   +5 more
europepmc   +1 more source

Weight-Lowering Drugs and Natural Female Fertility-A Systematic Review and Meta-Analysis. [PDF]

Clin Obes
Alnaimi SJ, Alsugeir DM, Wei L, Harvey K, Brauer R.   +4 more
europepmc   +1 more source

Intestinal lipase inhibition uncouples diet-induced obesity from MASH by remodeling the hepatic lipidome in mice. [PDF]

J Lipid Res
Chan AP, Czernuszewicz TJ, Lai RW, Jarrett KE, Lau A, Warshan A, Cheng AS, Steel ME, Schmidt HM, Larios J, Little I, Rubert GE, Brearley-Sholto MC, Mamouei Z, Pesner JK, Hamad CD, Francis KP, Bernthal NM, Redente EF, Magyar CE, French SW, Williams KJ, Tarling EJ, de Aguiar Vallim TQ.   +23 more
europepmc   +1 more source

A community-engaged randomized controlled trial assessing the effectiveness of a weight loss aid in reducing the body burden of persistent organic pollutants. [PDF]

Environ Adv
Terrell ML, Tomlinson MS, Wolfe J, Hood RB, Pearson MA, Barton H, Dadani S, Morse J, Barr DB, Havlicek B, Fremion BB, Jelenek J, Keon N, Corbett TH, Montoye AHK, Hartman TJ, Manatunga A, Marcus M.   +17 more
europepmc   +1 more source